NO347094B1 - Method for elimination of microorganisms - Google Patents
Method for elimination of microorganisms Download PDFInfo
- Publication number
- NO347094B1 NO347094B1 NO20220614A NO20220614A NO347094B1 NO 347094 B1 NO347094 B1 NO 347094B1 NO 20220614 A NO20220614 A NO 20220614A NO 20220614 A NO20220614 A NO 20220614A NO 347094 B1 NO347094 B1 NO 347094B1
- Authority
- NO
- Norway
- Prior art keywords
- salt solution
- aqueous salt
- microorganisms
- substrate surface
- log
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 53
- 244000005700 microbiome Species 0.000 title claims description 33
- 230000008030 elimination Effects 0.000 title claims description 17
- 238000003379 elimination reaction Methods 0.000 title claims description 17
- 239000012266 salt solution Substances 0.000 claims description 79
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 39
- 235000002639 sodium chloride Nutrition 0.000 claims description 29
- 241000700605 Viruses Species 0.000 claims description 25
- 241000894006 Bacteria Species 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 18
- 230000009467 reduction Effects 0.000 claims description 17
- 235000019795 sodium metasilicate Nutrition 0.000 claims description 14
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 14
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 14
- 229910000406 trisodium phosphate Inorganic materials 0.000 claims description 14
- 235000019801 trisodium phosphate Nutrition 0.000 claims description 14
- 159000000011 group IA salts Chemical class 0.000 claims description 11
- 241000233866 Fungi Species 0.000 claims description 10
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- -1 pyrosilicate Chemical compound 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 25
- 239000000645 desinfectant Substances 0.000 description 22
- 231100000021 irritant Toxicity 0.000 description 22
- 239000002085 irritant Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- 238000001035 drying Methods 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 230000000840 anti-viral effect Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229920000742 Cotton Polymers 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 241001105894 Murine norovirus Species 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 239000003139 biocide Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000001332 colony forming effect Effects 0.000 description 5
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 238000009877 rendering Methods 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 241000701161 unidentified adenovirus Species 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 230000000120 cytopathologic effect Effects 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052605 nesosilicate Inorganic materials 0.000 description 4
- 150000004762 orthosilicates Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001135569 Human adenovirus 5 Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000004075 alteration Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 239000013553 cell monolayer Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001263478 Norovirus Species 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000006161 blood agar Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 230000003253 viricidal effect Effects 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000984682 Candida africana Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 229910020451 K2SiO3 Inorganic materials 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/08—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/26—Phosphorus; Compounds thereof
Description
FIELD OF INVENTION
The present disclosure relates to a method for elimination of microorganisms on a substrate surface. More specifically, the disclosure relates to a method for elimination of microorganisms on a substrate surface as defined in the introductory parts of the independent claims.
BACKGROUND OF THE INVENTION
Removal of infective agents like bacteria, virus and fungi from surfaces like skin, benches, tables, handles, rails, armrests, car interior and similar, is important in hygienic control regimes. For these purposes, a variety of biocide agents has been introduced covering all aspects from intensive cleaning of hospital surgery units to daily disinfection of hand surfaces. For many purposes where human skin or mucous membranes are not involved, acting agents like chlorine‐ and other halogen‐based compounds, quaternary ammonia compounds, strong detergents and various organic solvents are often used. For purposes like rinsing of human skin and more sensitive materials that should not be damaged, decolorized or in any other way damaged, less aggressive chemical substances or compositions are desirable. Among such disinfectant solutions frequently used are ordinary hand‐soap, mildly acting detergent solutions, various alcohols or alcohol mixtures like ethanol, propan‐2 ol, or a mixture of these. Also, low concentration hypochlorite solutions or other halogen‐based solutions as well as low concentrations of various quaternary ammonia compounds and hydrogen peroxide are used.
Practical use of current biocides is often hampered by various disadvantages. Although ordinary hand‐soap and detergent solutions are efficient, they can act toxic is swallowed, are irritant upon contact with eyes or mucous membranes, and require the presence of water and towels that often render it less convenient for the users’ purposes. Likewise, solutions of alcohols are efficient, and although ready‐made and more convenient than soap and water it is hampered by being highly flammable, toxic, irritant to eyes and mucous membranes, and is dehydrating skin and certain synthetic materials like «Skai» that is frequently used in car interior. Alcohols and other organic solvents may also affect the quality of materials used in furniture, and related applications. Other biocide compositions like hydrogen peroxide and those containing halogen‐based compounds may be irritant and toxic, even in low
concentrations. Furthermore, they may cause discoloration and may also leave an unpleasant
smell.
Applications using traditional soaps with an alkaline pH are also widely known. However, such
soaps typically created a pH in the range 9.5‐10.5 when mixed with water, and have their
biocidal effect through the detergent fatty acids. Furthermore, soap‐water solutions are not
acting biocidal by drying in on the surfaces applied to, but is rather rinsed off with water.
Prior art documents disclosing disinfectants and methods of elimination microorgansims are such as:
STEDMAN RL., KRAVITZ E., BELL H. Studies on the efficiencies of disinfectants for use on inanimate objects. I. Relative activities on a stainless steel surface using a new performance test method. Appl Microbiol, 1954, vol. 2, no. 3, p 119‐124;
WO2019160875 disclosing antibacterial agents comprising soluble salts and aqueous formulations of pyronins; and
GB2541907 disclosing fungicide for the treatment of fungal pathogens causing mycotoxins.
The important factors desirable for disinfection methods are 1) efficient elimination of
unwanted microorganisms, 2) ready‐made solution that can conveniently be used at the site
with no use of other items, 3) not causing damage or altering the surfaces it is used on, 4) non-
irritant or non‐toxic, and 5) environmentally friendly.
The inventor have noticed that such properties can be obtained by application of solutions of
alkaline salts, preferably inorganic salts that are environmentally friendly, and when applied
according to a distinct, but simple procedure.
Thus, there is still a need in the art to search for new disinfectant solutions and methods for
removal of unwanted microorganisms from surfaces.
It may be seen as another object of the invention to wholly or partly overcome the
disadvantages and drawbacks of the disinfective principles known from the prior art,
particularly for applying a disinfectant solution for the described purpose that is user friendly,
non‐toxic, non‐irritant, not flammable, and environmental friendly.
SUMMARY OF THE INVENTION
It is an object of the present disclosure to mitigate, alleviate or eliminate one or more of the above‐identified deficiencies and disadvantages in the prior art and solve at least the above mentioned problem.
By the present invention it has surprisingly been found that applying an aqueous solution of preferentially inorganic salts, that are able to generate a pH in the range 11‐12.5, to various surfaces like human skin, furniture, rails, benches and tables, car interior, handles; allowing said aqueous salt solution to dry in thereby creating a concomitant rise in pH, and thereafter turning non‐irritant as the pH is lowered to <10 by contact with air.
Thus, a first aspect of the invention provides a method for elimination of microorganisms on a substrate surface comprising the following steps: i) applying to the substrate surface an aqueous salt solution of alkaline salts having a pH in the range of 11 to 12.5, ii) allowing the aqueous salt solution to dry in on the substrate surface, and optionally iii) exposing the substrate surface to air after the aqueous salt solution has dried in.
Thus, according to some embodiments, said alkaline salts are selected from the group consisting of metasilicate, orthosilicate, pyrosilicate, phosphate, hydroxide, carbonate, borate and any combinations thereof. Preferably, the metasilicates, orthosilicates, pyrosilicates, phosphates, or carbonates are present in concentrations of 0.5 – 25 mmol/L.
According to some embodiments, the cations of the alkaline salts are selected from the group consisting of sodium and potassium.
According to some embodiments, the aqueous salt solution further comprises sodium chloride to provide an osmolarity of 308 ± 50 mosmol/L.
According to some embodiments, the aqueous salt solution comprises Na2SiO3, Na3PO4 and NaCl. In a preferred embodiment, the aqueous salt solution comprises Na2SiO3 in a concentration ranging from about 5 to 15 mmol/L, Na3PO4 in a concentration ranging from about 1 to 2 mmol/L and NaCl in a concentration ranging from about 0.05 to 0.15 mol/L. In a particularly preferred embodiment, the aqueous salt solution consists of 8 mmol/L Na2SiO3,
1.5 mmol/L Na3PO4 and 0.1 mol/L NaCl. The aqueous salt solution is non‐irritant to human skin.
According to some embodiments, the elimination of microorganisms are determined by a reduction in the microorganism count by at least 2 log, preferably at least 3 log, and most preferably at least 4 log as measured by European Standard EN 16615.
According to some embodiments, said microorganisms are selected from the group consisting of bacteria, fungi, and viruses.
The present disclosure will become apparent from the detailed description given below. The detailed description and specific examples disclose preferred embodiments of the disclosure by way of illustration only. Those skilled in the art understand from guidance in the detailed description that changes and modifications may be made within the scope of the disclosure.
Hence, it is to be understood that the herein disclosed disclosure is not limited to the particular component parts of the device described or steps of the methods described since such device and method may vary. It is also to be understood that the terminology used herein is for purpose of describing particular embodiments only, and is not intended to be limiting. It should be noted that, as used in the specification and the appended claim, the articles "a", "an", "the", and "said" are intended to mean that there are one or more of the elements unless the context explicitly dictates otherwise. Thus, for example, reference to "a unit" or "the unit" may include several devices, and the like. Furthermore, the words "comprising", "including", "containing" and similar wordings does not exclude other elements or steps.
In this context the term aqueous salt solution, disinfection solution and disinfectant solution are used interchangeably.
BRIEF DESCRIPTIONS OF THE DRAWINGS
The above objects, as well as additional objects, features and advantages of the present disclosure will be more fully appreciated by reference to the following illustrative and non‐
limiting detailed description of example embodiments of the present disclosure, when taken in conjunction with the accompanying drawings.
Figure 1 shows pH vs time for drying in the disinfectant solution on a surface.
Figure 2 shows pH alteration in disinfectant solution on exposure to air. Figure 3 shows reduction in CFU after application of disinfectant solution on human skin.
DETAILED DESCRIPTION
The present disclosure will now be described with reference to the accompanying drawings, in which preferred example embodiments of the disclosure are shown. The disclosure may, however, be embodied in other forms and should not be construed as limited to the herein disclosed embodiments. The disclosed embodiments are provided to fully convey the scope of the disclosure to the skilled person.
The invention relates to a method for removal of unwanted microorganisms from surfaces, and in particular surfaces that are sensitive to more aggressively acting chemicals, applying an aqueous salt solution. Furthermore, the invention seeks to avoid the use of disinfectant chemicals that produce unpleasant, irritant or even toxic gases. Surfaces particularly useful for disinfection according to the invention are, but not limited to, human or animal skin, skin based products like leather, synthetic materials like car interior materials commonly known as «Skai», surfaces in areas for human or veterinary medical and/or dental procedures, areas and machinery for food production, and restaurants and other publically visited areas like public transport vehicles, meeting rooms or exhibition facilities. The method may also be useful for surface disinfection of fruits, vegetables and berries.
In comparison, methods applying commonly used disinfectants are hampered by various disadvantages like creating irritant reactions to skin and mucous membranes, toxic effects to animals and humans, damaging surface materials, and generating irritant or even toxic vapours and gases.
Thus, the object of the current invention is to providing a method that lacks most of the disadvantages related to application of disinfectant media in the prior art, and still be able to remove unwanted microorganisms from various surfaces.
Thus, the first aspect of the invention is directed to a method for elimination of microorganisms on a substrate surface comprising the following steps: i) applying to the substrate surface an aqueous salt solution of alkaline salts having a pH in the range of the 11 to 12.5; ii) allowing the aqueous salt solution to dry in on the substrate surface; and optionally iii) exposing the substrate surface to air after the aqueous salt solution has dried in.
It is evident that the method according to the invention is most efficient when the aqueous salt solution is allowed to dry in. In particular, this may be a precaution for efficient elimination of more biocide resistant Gram+ bacteria like those of the Staphylococcus strain. Thus, as part of the invention is a particular use of the aqueous salt solution by allowing it to dry in after application to surfaces.
The aqueous salt solution applied is preferably based on inorganic salts commonly occurring in the nature, able to generate a pH in the range 11‐12.5. Particularly useful inorganic salts are metasilicates, orthosilicates, pyrosilicates, phosphate, hydroxide, carbonate, borate and any combinations thereof. Preferably, metasilicates, orthosilicates, pyrosilicates and phosphate combined with hydroxide ions to arrive at the desired pH may be useful. It should however, be understood that also any other salts with similar properties are useful. Thus, also quaternary organic amino salts can be applied. In principle, any cationic counter ions can be used for the above‐mentioned salts, but sodium and potassium ions are in particular useful. Thus, examples of salts that can be used in the solution are, but not limited to, Na2SiO3, K2SiO3, Na4SiO4, K4SiO4, Na6Si2O7, K6SiO2O7, Na3PO4, K3PO4, NaOH, KOH, Na2CO3, K2CO3. Preferably, metasilicates, orthosilicates, pyrosilicates and phosphate combined with hydroxide ions to arrive at the desired pH may be useful.
In order to create a disinfection method with limited irritant consequences, the present invention takes advantage of the property that the aqueous salt solution applied is gradually neutralised when exposed to certain surfaces or to air, and when the above mentioned salts in the solution are preferably used in concentrations of 0.5 – 25 mmol/L, although the invention is not limited to application of aqueous salt solution with such concentrations.
In preferred embodiments, the aqueous salt solution comprises Na2SiO3, Na3PO4 and NaCl. In a preferred embodiment, the aqueous salt solution comprises Na2SiO3 in a concentration ranging from about 5 to 15 mmol/L, Na3PO4 in a concentration ranging from about 1 to 2 mmol/L and NaCl in a concentration ranging from about 0.05 to 0.15 mol/L. In a particularly preferred embodiment, the aqueous salt solution consists of 8 mmol/L Na2SiO3, 1.5 mmol/L Na3PO4 and 0.1 mol/L NaCl.
A further aspect of proving a method for disinfection with a minimum irritant action is to apply an aqueous salt solution where a further inorganic salt, preferentially sodium chloride, is added to provide an isotonic solution targeting 308 mosmol/L or an almost isotonic solution of 308 + 50 mosmol/L. Application of such salt compositions prove to be almost non‐irritant, even in contact with mucous membranes. Thus, in a preferred embodiment the present invention relates to an aqueous salt solution further comprising sodium chloride to provide an isotonic salt solution, i.e. to provide an osmolarity of 308 + 50 mosmol/L.
The method of the invention prove to have very favourable properties. Figure 1 shows the development of pH after distribution to a surface. The version of disinfectant solution used in this case has the composition of 8 mmol/L Na2SiO3, 1.5 mmol/L Na3PO4 and 0.1 mol/L NaCl. As the aqueous salt solution dries in, the pH rise to about 13 when the least measurable volume is left (about 10%), and probably rise even more just before the aqueous salt solution dries in.
A long‐lasting exposure of human skin to such levels of pH would for most circumstances be regarded harmful. However, a patch‐test where the disinfection method is used on human skin proves that the procedure surprisingly could be classified «non irritant».
Figure 2 shows how pH of the aqueous salt solution develops over time. Starting with a version of the aqueous salt solution concentrated 10 times the composition described above, i.e. 8 mmol/L Na2SiO3 , 1.5 mmol/L Na3PO4 and 0.1 mol/L NaCl, this mimics the situation when the disinfectant solution is dried in to 10% of the original volume, and the pH when newly mixed could be measured to 13.1. When 5 mL of this concentrated aqueous salt solution is left in a petridish to generate a large surface exposed to air, pH in the solution surprisingly drops rapidly and after about 20 minutes flattens out at about pH 9.5, a pH‐level considered harmless for most circumstances.
Although not wishing to be bound by any theory, it is believed that the entire effect of applying the aqueous salt solution is that it gives a temporary rise in pH sufficient to kill most microorganisms, followed by a subsequent drop in pH rendering the disinfectant solution at a harmless pH‐level after short time.
The invention relates to the method of applying an aqueous salt solution for removal of microorganisms. For application to various surfaces like human skin, furniture, rails, handles, the maximum disinfectant properties of the method is obtained when allowed to dry in on the surfaces applied to. This procedure creates a certain rise in pH, efficiently eliminating microorganisms, and thereafter surprisingly turning non‐irritant as the pH lowers to <10 by contact with air and/or surfaces like skin. Thus, a test on human skin applying the aqueous salt solution at a pad to 20 volunteers rendered no skin damage or irritant reactions even after days covered by a plaster. Thus, the aqueous salt solution provided is non‐irritant to human skin.
The method according to the invention applying the aqueous salt solution efficiently eliminates microorganisms such as bacteria, fungi, and viruses. Examples of viruses are all enveloped viruses thus including, but not limited to, adenovirus, norovirus, rotavirus and coronavirus. Furthermore, the method efficiently eliminates bacteria from strains like Escherichia, Staphylococcus, Pseudomonas, Salmonella, and Vibrio by > log 5. Furthermore, the method efficiently eliminates fungi such as fungi from the strain Candida by log > 5. When considering the general meaning of the term «removal of unwanted microorganisms» it is not evident that any complete removal is obtained. Elimination of microorganisms will rather be considered as a reduction in microorganism count by at least 2 log, preferably at least 3 log, and most preferably a least 4 log as measured by the European Standard EN 16615. Thus, in preferred embodiments, the elimination of microorganisms are determined by a reduction in the microorganism count by at least 2 log, preferably at least 3 log, and most preferably at least 4 log as measured by European Standard EN 16615.
It is evident that the method according to the invention is most efficient when the aqueous salt solution is allowed to dry in. In particular, this may be a precaution for efficient elimination of more biocide resistant Gram+ bacteria like those of the Staphylococcus strain. Thus, as part of the invention is a particular use of the aqueous salt solution by allowing it to dry in after application to surfaces.
The concept of «drying in» shall generally mean that in the context of this invention a visual inspection of a surface where the method is applied to, is not rendering any visible liquid. However, common understanding of the term «dry» does not necessarily mean «water free» since it is not likely that water can be completely removed from a surface whereto the method according to the invention is applied, because the remaining salt layer of the treated surface will necessarily be exposed to air that for all practical purposes will contain a certain level of water vapour. «Drying in» will for most purposes occur within two minutes after application of the aqueous salt solution to a surface. However, it is evident that the time for drying in will depend on many factors like amount of liquid applied to a given surface area, the temperature, air moisture, ventilation a.s.o.
Certain applications tested did not include a step of drying in of the aqueous salt solution, demonstrating that after prolonged exposure of the microorganisms in an aqueous environment the aqueous salt solution even so had significant effect on the microorganism counts. However, application of the aqueous salt solution to a surface will not allow any long standing exposure to an excess of this solution, and the effect of the aqueous salt solution must be potentiated through letting it dry in to rise the pH.
The concept of «application to a surface» is generally meaning that the aqueous salt solution is evenly distributed on the desired part of a surface where microorganisms should be removed, so that the entire surface is covered. The application of the aqueous salt solution may be performed by any convenient means like spraying, clothing, swabbing, dipping etc.
The invention will now be further illustrated with reference to the following non‐limiting examples.
EXAMPLES
Example 1
An alkaline aqueous salt solution was made by adding to water Na2SiO3 to arrive at a concentration of 8 mmol/L, Na3PO4 to arrive at a concentration of 1.5 mmol/L and 0.1 mol/L NaCl. This aqueous salt solution had a pH of 12.0 + 0.1.
Unless otherwise remarked, this version of the aqueous salt solution was used in the further examples.
Example 2 A test demonstrating the effect of drying in of the aqueous salt solution for maximum effect on certain micro‐organisms, was performed. The standard protocol for antiseptics EN 16615 «4‐Field Test» was applied for this experiment. The bacteria and fungal species tested were
1. Stapholycoccus aureus ATTC 25923 (bacterium) 2. Escherichia coli ATTC 25922 (bacterium)
3. Candida africana (fungi)
The bacteria and fungi were cultivated in LB medium overnight at 37°C while shaking. 0-samples and stock solutions were seeded for each experiment.
1. For each of the aforementioned species tested, two parallel squares of 5X5cm<2> were marked on a surface of stainless steel. Each square was inoculated with 50µl, approx. 1 x 10<9> CFU and allowed to dry for about 1h.
2. Thereafter one square was sprayed with sufficient disinfectant solution to allow it stay liquid for at least 15 minutes, whereas the other square was sprayed with less disinfectant solution rendering this square dry after about 5 min.
3. Shortly thereafter, and then after 1, 5, 10, and 15 min, samples were absorbed from each square by means of a cotton swab. Two cotton swabs and a tube with bovine serum albumin, BSA, were used per sampling. Firstly, a cotton swab saturated with BSA‐solution was rubbed over a square and then placed in 10ml BSA solution by cutting off the stick end. Furthermore, a dry cotton stick was rubbed over the same square and its tip was cut off and placed in the same tube as above. BSA neutralised the further effect of the aqueous salt solution. The tube was shaken for 15 seconds. 100 µl of this suspension was cultivated on blood agar plates and incubated at 37°C over night before counting the colonies. The results are shown in table1 below:
Table 1
* Colony Forming Units
To pass the test according to the standard EN 16615 «4‐Field Test», at least a 5 log reduction of bacteria (S.aureus and E.coli) or at least a 4 log reduction of fungi (Candida) should be obtained. As can be seen from the table, this requirement is fulfilled. However, it can be seen that for a more biocide resistant G+ bacteria like S.aureus, a full effect is most likely obtained after the aqueous salt solution is allowed to dry in.
Example 3
The aqueous salt solution was tested for its effect on bacteria on human skin, according to the same test principle as described in Example 2. A square of 5X5cm<2> was drawn on the palm of the inventor, and the square area was inoculated with 50µl suspension of Staphylococcus aureus. After the bacterial culture had dried in, the aqueous salt solution was sprayed on to the square, and samples were taken by a cotton swab immediately after application and the subsequently after 1, 2, 3, 4 and 5 min. The palm was considered dry after about 2‐3 minutes. The samples were further handled and cultivated as in Example 2.
The CFU of the stock solution applied was 3 x 10<10>. After 5 min at the palm, when completely dried in, the CFU was 9 x 10<5>, thus rendering a CFU reduction close to 5 log.
The reduction in CFU after application of disinfection solution is set forth in Figure 3.
Example 4
Test on effect on bacteria in unclean water was performed according to the method /criteria given in NS‐EN ISO 6222‐1 and NMKL 125 ‐4. Water from a slightly polluted creek was mixed 1:1 with the aqueous salt solution of the invention, incubated at 20<o>C for five minutes and subsequently tested for colony‐forming bacteria after application to blood agar plates and incubation at 37<o>C overnight. The test showed that >99% of unspecified, cultivable, colonyforming, bacterial species were eliminated. The test shows that the aqueous salt solution has significant anti‐microbial properties when allowed to be exposed to bacteria over time, and without applying the drying in procedure that is considered necessary on short time exposure.
Example 5
Test on effect on bacteria on a laminated laboratory bench plate surfaces was performed by applying a thin layer of a liquid suspension of the bacterium Escherichia coli to the actual surface, and allowed to dry. Distinct segments areas of the polluted bench surface was then treated by 1) No washing; 2) Washing with tap water; and 3) Washing by application of the aqueous salt solution that was allowed to dry in. The respective surface areas were thereafter tested in to parallels with petrifilm for colony forming bacteria as shown in Table 2 below:
Table 2
Example 6
Aqueous salt solution and a control liquid (0.9% NaCl) were added to bacterial cultures to 20% v/v. The bacterial cultures contained 2.5 – 5.7 x 10<6 >bacteria/mL. The cultures were left at 20<o>C for 3, 6 and 24 hours and subsequently tested for colony forming bacteria on agar plates. The control culture added only 0.9% NaCl increased in bacterial numbers, as expected. The other samples added aqueous salt solution demonstrated a marked reduction of living bacteria as shown in table 3 below.
Table 3
There was consequently a significant, and for practical purposes, a full elimination of the bacteria tested after treatment of the cultures with aqueous salt solution also without drying in on a substrate, when the exposure time was sufficiently long.
Example 7
Antiviral effect of the aqueous salt solution was tested.
Firstly, any cytotoxic effect of the disinfectant solution under the experimental conditions to be used was determined on the eukaryotic cells: Human epithelial type 2 (Hep‐2) cells; Human Rhabdomyosarcoma cells (RD); RAW 264.7 macrophage (ATCC). Dilutions 10<‐1> to 10<‐8> of the disinfective solution in culture medium with 3.0 g/L BSA plus 3,0 ml/l erythrocytes were incubated in ice‐cold water for 30 min and then 100 μL of each dilution were inoculated onto monolayers of Hep‐2, RD and RAW cells in the wells of culture plates. Any microscopic changes in the cells after 5‐days incubation were recorded.
No cytotoxic effect was observed on Hep‐2, RD and RAW cells in all dilutions of the Disinfective Solution under the described conditions thus rendering the experiments with the Disinfective Solutions effects on virus possible.
The anti‐viral test was performed according to 14476:2013+A2:2019: "Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of virucidal activity in the medical area ‐ Test method and requirements (Phase2/Step 1)".
The viruses tested were: Adenovirus type 5 (ATCC VR‐5); and Murine Norovirus (Strain S99 Berlin)
The cells used for viral infection were: Human epithelial type 2 (Hep‐2) cells; Human Rhabdomyosarcoma cells (RD);
Principle of the test: A 97% dilution of the aqueous salt Solution was added to a test suspension of titrated viruses in bovine serum albumin solutions of 3.0 g/L plus 3,0 ml/l erythrocytes (dirty conditions). The mixtures were maintained at 20<o>C for 3 min. At the end of contact time, an aliquot was taken and the virucidal activity was suppressed by dilutions in icecold maintenance medium. The dilutions were then inoculated onto cell monolayers in 96‐well culture plates for the titration of the remaining viruses. The titers of the viruses expressed in TCID50 values, after 5‐days incubation, were determined and expressed in log scale. Reduction of the viruses’ infectivity was calculated from the differences of the log virus titers before (control) and after treatment with the product. According to the EN 14476 standard a product has antiviral activity when the reduction of the virus is at least 4 lοg.
The viruses were propagated in the appropriate cell culture system to produce a high titer: Hep‐2 monolayers for adenovirus titration, and RAW cell monolayers for M.norovirus titration. Each virus was tested in decimal dilutions 10<‐3> up to 10<‐10>. Each dilution was inoculated 10x in wells of 96‐well culture plates with the appropriate cell monolayer. The infected cells were incubated at 37<o>C in a 5% CO2 atmosphere for 5 days. The Tissue Culture Infectious Dose (TCID50) i.e. the infection dose of a virus suspension inducing a Cytopathic Effect (CPE) in 50% of cell culture units was estimated by the end‐point Spearman‐Karber method:
Log TCID50 = L‐d(S‐0.5), where L is the highest virus concentration used, d is the log difference of dilutions, S is the sum of % affected (CPE) at each dilution.
By using of the Spearman‐Karber formula on the aforementioned CPE results, the calculated TCID50 of the Adenovirus, and the Norovirus strains were 10<‐7.9 > and 10<‐7.5> respectively. Taking into account the standard error of the above calculation, the titers of the three strains used in the tests were
Initial titer of Adenovirus type 5 Log TCID50/0.1mL = 7.9±0.163 Initial titer of Murine norovirus Log TCID50/0.1mL = 7.5±0.141 Formaldehyde 0.7% (w/v) was included as reference for test validation. Cytotoxicity test as well as antiviral activity determination was performed on RD cells using serial dilutions of up to 10<‐8> of the aforementioned formaldehyde test solution. Contact times were 30 min and 60 min.
The antiviral activity of the product against the adenovirus, and murine norovirus strains was determined for 3 min at 20+1 <o>C in 3.0 g/L (dirty conditions). Immediately at the end of contact time, a 1/10 dilution was made in ice‐cold cell maintenance medium and 30 min later, subsequent serial dilutions (step 1:10) were inoculated onto cell culture monolayers. After incubation, the titer of each virus was calculated, and the reduction of the virus infectivity was determined from the log differences of virus titers before and after treatment with the product.
A sufficient antiviral activity of the aqueous salt solution would require a reduction of at least 4 lοg of the viruses tested. The test demonstrated: a 5.2 log reduction of the Adenovirus type 5 (ATCC VR‐5), a ≥6.0 log reduction of the Murine Norovirus (Strain S99 Berlin). The disinfectant solution thus demonstrated antiviral activity according to EN14476 against the viruses tested. According to the EN 14476 standard, products that have antiviral activity against the adenovirus and the murine norovirus are considered active against all enveloped viruses further also including, but not limited to, rotavirus and coronavirus. This effect is thus taking place also without the "drying‐in‐step» which renders it likely that when drying in is performed, the viral elimination effect will be even more abundant than shown in this example.
Example 8 A test on assessment of skin tolerance of the aqueous salt solution was performed. After a single application of aqueous salt solution followed by 48 hours occlusive patch on 20 human volunteers was conducted in accordance with all international ethical standards and regulations, and in particular the COLIPA Guidelines edited on 1997 for the “Product Test Guidelines for the Assessment of Human Skin Compatibility”.
Patch test is the assessment of skin tolerance of a product that normally will be used for skin applications, and involves a single application during 48 hour occlusive patch test. Negative controls are used to facilitate evaluation. Treatment sites are assessed before the first application of the test material (baseline), after treatment at 30 minutes, upon patch removal and at 24 and 48 hours after patch removal. The patch is applied on the skin for 48 hours. Skin reactions are scored throughout the test by the same experienced assessor, a dermatologist, who made the baseline assessment and under the same lighting source, following a predefined scoring scale. The quantification of the skin irritation is given through a numeric scale (erythema, oedema, dryness/desquamation, vesicles). The average irritant score of the product tested is calculated from the average of the reactions obtained for each volunteer, allowing to rank the product from "non irritant to very irritant" as shown in Table 4 below.
Table 4
Of the 20 subjects studied, 10 were considered having «normal skin», whereas 10 were considered having «sensitive skin». Testing of the aqueous salt solution resulted in an average irritant score of the product at 0.03. The conclusion thus was that the method of the current invention can be considered as «Non irritant» regarding its primary skin tolerance.
Example 9
The potential effect of application of the aqueous salt solution to a variety of materials was investigated in order to identify potential damages, discolouration or in other ways other unacceptable alterations when applied the Disinfectant Solution was applied to:
Car interior (Skai)
Natural leather
Coloured leather
Coloured wool
Coloured cotton
Coloured acryl
Coloured viscose
Coloured polyester
Aqueous salt solution was sprayed on distinct areas of each test‐material in doses of 2 x 1 mL, and allowed to dry in. A control solution with 0.9% NaCl was applied next to the aqueous salt solution. The test‐materials were then left at room temperature. Visual inspections of the materials were performed daily to look for any changes to colour or texture. After two weeks, none of the materials tested showed any sign of alteration thus indicating the procedure is safe to use on a variety of surfaces and materials.
Claims (8)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20220614A NO347094B1 (en) | 2022-05-25 | 2022-05-25 | Method for elimination of microorganisms |
PCT/NO2023/050122 WO2023229468A1 (en) | 2022-05-25 | 2023-05-24 | Method for elimination of microorganisms |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20220614A NO347094B1 (en) | 2022-05-25 | 2022-05-25 | Method for elimination of microorganisms |
Publications (2)
Publication Number | Publication Date |
---|---|
NO347094B1 true NO347094B1 (en) | 2023-05-15 |
NO20220614A1 NO20220614A1 (en) | 2023-05-15 |
Family
ID=86548533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20220614A NO347094B1 (en) | 2022-05-25 | 2022-05-25 | Method for elimination of microorganisms |
Country Status (2)
Country | Link |
---|---|
NO (1) | NO347094B1 (en) |
WO (1) | WO2023229468A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2541907A (en) * | 2015-09-03 | 2017-03-08 | Agronaturalis Ltd | Fungicide for the treatment of fungal pathogens causing mycotoxins |
WO2019160875A1 (en) * | 2018-02-13 | 2019-08-22 | Rutgers, The State University Of New Jersey | Antibacterial agents: soluble salts and aqueous formulations of pyronins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6790816B2 (en) * | 1999-09-24 | 2004-09-14 | Bausch & Lomb Incorporated | High osmolyte cleaning and disinfection method and solution for contact lenses |
US6752848B2 (en) * | 2001-08-08 | 2004-06-22 | N-Viro International Corporation | Method for disinfecting and stabilizing organic wastes with mineral by-products |
CA2962787A1 (en) * | 2017-03-30 | 2018-09-30 | Siamons International Inc. | A disinfectant composition with extended antimicrobial effects |
-
2022
- 2022-05-25 NO NO20220614A patent/NO347094B1/en unknown
-
2023
- 2023-05-24 WO PCT/NO2023/050122 patent/WO2023229468A1/en active Search and Examination
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2541907A (en) * | 2015-09-03 | 2017-03-08 | Agronaturalis Ltd | Fungicide for the treatment of fungal pathogens causing mycotoxins |
WO2019160875A1 (en) * | 2018-02-13 | 2019-08-22 | Rutgers, The State University Of New Jersey | Antibacterial agents: soluble salts and aqueous formulations of pyronins |
Non-Patent Citations (1)
Title |
---|
D1: STEDMAN RL., KRAVITZ E., BELL H. Studies on the efficiencies of disinfectants for use on inanimate objects. I. Relative activities on a stainless steel surface using a new performance test method. Appl Microbiol, 1954, vol. 2, no. 3, side 119-124., Dated: 01.01.0001 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023229468A1 (en) | 2023-11-30 |
NO20220614A1 (en) | 2023-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3136861B1 (en) | Composition containing peroxide and an antimicrobial agent and process of killing spores | |
Dvorak | Disinfection 101 | |
RU2423049C2 (en) | Composition (versions) and methods of processing | |
US8110538B2 (en) | Peracid/peroxide composition and use thereof as an anti-microbial and a photosensitizer | |
US5320805A (en) | Methods of using a cleaner, sanitizer, disinfectant, fungicide, sporicide, chemical sterilizer | |
Oule et al. | Akwaton, polyhexamethylene-guanidine hydrochloride-based sporicidal disinfectant: a novel tool to fight bacterial spores and nosocomial infections | |
CA2884060C (en) | A prolonged disinfectant composition for non-biological surfaces comprising silver ion water and aloe vera | |
Rushdy et al. | Bactericidal efficacy of some commercial disinfectants on biofilm on stainless steel surfaces of food equipment | |
KR20050048630A (en) | Biocide composition and related methods | |
JP2009040760A (en) | Sterilizing and virus-removing agent and sterilizing and virus-removing method | |
NO347094B1 (en) | Method for elimination of microorganisms | |
CN102648710B (en) | Compound glutaraldehyde disinfectant for body of dead person | |
Elkhatat | Recent trends of microbial decontamination for occupational, industrial and domestic applications | |
US11425911B2 (en) | Method for disinfection of items and spaces | |
RU2646816C1 (en) | Decontaminant for refilling of household aerosol sprayers for decontamibation of the air environment and indoor surfaces | |
CN102461499B (en) | Disinfector for remains and preparation method thereof | |
Sojitra et al. | Saltwater as a Disinfectant and Cleaning agent for Environmental Surfaces in the context of SARS-COV-II. | |
US11965145B2 (en) | Hard surface cleaner | |
US11825846B2 (en) | Method for disinfection of items and spaces | |
US10968418B1 (en) | Compositions for maintaining clean surfaces and methods for making and using clean surface technology | |
BOONCHAN | EFFICACY OF HYDROXYL RADICAL AEROSOLIZATION FOR INDUSTRIAL SURFACE SANITATION AND HIGH-RISK AREA FUMIGATION | |
Abd-Elall et al. | Antibiofilm Effect of Commonly Used Chemical Disinfectants on Certain Bacterial Species Isolated from Poultry Abattoirs | |
Ditchett | 15 Disinfection | |
Karahmet et al. | The evaluation of chlorine dioxide efficiency used in the dairy plants disinfection. | |
EP4228407A1 (en) | Antimicrobial composition, particularly bactericidal, virucidal, fungicidal and mycobacterial for the cleaning of contaminated surfaces and its use |